A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer
Clinical trial NCT03414047 · COMPLETED
Trial details
- NCT number
- NCT03414047
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-10
- Primary completion
- 2019-06-03
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.